Operating Lease, Right-of-Use Asset of Oric Pharmaceuticals, Inc. from 30 Sep 2021 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Oric Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2021 to 31 Dec 2024.
  • Oric Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $8,380,000, a 8.4% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Oric Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $8,380,000 -$764,000 -8.4% 31 Dec 2024 10-K 18 Feb 2025 2024 FY
Q4 2023 $9,144,000 -$1,844,000 -17% 31 Dec 2023 10-K 18 Feb 2025 2024 FY
Q4 2022 $10,988,000 -$812,000 -6.9% 31 Dec 2022 10-K 11 Mar 2024 2023 FY
Q4 2021 $11,800,000 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $12,000,000 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.